+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hypercholesterolemia Drug"

Global Hypercholesterolemia Drug Market by Mechanism of Action (Bile Acid Sequestrants, Fibric Acid Derivatives, HMG-CoA Reductase Inhibitors), Type of Disease (Familial hypercholesterolemia (FH), Non-Familial hypercholesterolemia (FH)), Drug Class - Forecast 2024-2030 - Product Thumbnail Image

Global Hypercholesterolemia Drug Market by Mechanism of Action (Bile Acid Sequestrants, Fibric Acid Derivatives, HMG-CoA Reductase Inhibitors), Type of Disease (Familial hypercholesterolemia (FH), Non-Familial hypercholesterolemia (FH)), Drug Class - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Global Hypercholesterolemia Drug Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Hypercholesterolemia Drug Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 190 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 166 Pages
  • Global
From
Hypercholesterolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypercholesterolemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 80 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 188 Pages
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia - Pipeline Insight, 2024 - Product Thumbnail Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Global Dyslipidemia Drugs Market by Drug Class, By Indication, by Distribution Channel, and By Region - Product Thumbnail Image

Global Dyslipidemia Drugs Market by Drug Class, By Indication, by Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Metabolic Disorder Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration, By Disease (Diabetes, Lysosomal Disorders), By Therapy Type, By Region, and Segment Forecasts, 2019 - 2025 - Product Thumbnail Image

Metabolic Disorder Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration, By Disease (Diabetes, Lysosomal Disorders), By Therapy Type, By Region, and Segment Forecasts, 2019 - 2025

  • Report
  • January 2019
  • 145 Pages
  • Global
From
Hypercholesterolemia Market by Type, Diagnosis and Treatment, Patient, End User, and Region 2023-2028 - Product Thumbnail Image

Hypercholesterolemia Market by Type, Diagnosis and Treatment, Patient, End User, and Region 2023-2028

  • Report
  • January 2023
  • 145 Pages
  • Global
From
Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Familial Hypercholesterolemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Familial Hypercholesterolemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypercholesterolemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypercholesterolemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Disease Analysis: Dyslipidemia - Product Thumbnail Image

Disease Analysis: Dyslipidemia

  • Report
  • November 2020
  • 101 Pages
  • Global
Global Familial Hypercholesterolemia Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Familial Hypercholesterolemia Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 471 Pages
  • Global
From
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • March 2022
  • 1284 Pages
  • Global
From
Loading Indicator

The Hypercholesterolemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of high cholesterol levels. Hypercholesterolemia drugs are used to reduce the amount of cholesterol in the blood, which can help reduce the risk of heart attack and stroke. These drugs are typically prescribed to patients with high cholesterol levels, or those at risk of developing cardiovascular disease. Commonly prescribed drugs include statins, bile acid sequestrants, fibrates, and cholesterol absorption inhibitors. The Hypercholesterolemia Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, AstraZeneca, Novartis, and Bristol-Myers Squibb. Show Less Read more